tobramycin has been researched along with cyclic gmp in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
D'Argenio, DA; Hoffman, LR; Jones, RA; MacCoss, MJ; Miller, SI; Zhang, Z | 1 |
Chambers, JR; Cherny, KE; Sauer, K | 1 |
Braeckmans, K; Coenye, T; Kaever, V; Sass, A; Teirlinck, E; Van Nieuwerburgh, F; Wille, J | 1 |
Biavasco, F; Carotti, E; Cedraro, N; Citterio, B; La Teana, A; Mangiaterra, G; Vaiasicca, S | 1 |
4 other study(ies) available for tobramycin and cyclic gmp
Article | Year |
---|---|
Aminoglycoside antibiotics induce bacterial biofilm formation.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Biofilms; Cyclic GMP; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Genetic Complementation Test; Phenotype; Pseudomonas aeruginosa; Tobramycin | 2005 |
Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2017 |
Does the mode of dispersion determine the properties of dispersed Pseudomonas aeruginosa biofilm cells?
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Colistin; Cyclic GMP; Drug Resistance, Bacterial; Humans; Moths; Pseudomonas aeruginosa; Tobramycin | 2020 |
Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Biofilms; Ceftazidime; Cell Wall; Ciprofloxacin; Cyclic GMP; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transformation, Bacterial | 2021 |